HDAC11 and neuroblastoma: Other data demonstrated a significant role of HDAC11 in mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells and suggested that HDAC11 is potentially a valuable drug target (Thole et al., 2017).